References
  1. Asher MI, Montefort S, Björkstén B, Lai CK, Strachan DP, Weiland SK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006;368:733-43.
  2. Roberts G, Pfaar O, Akdis CA, Ansotegui IJ, Durham SR, van Wijk RG, et al. EAACI Guidelines on Allergen Immunotherapy: Allergic Rhinoconjunctivitis. Allergy. 2018;73(4):765-798.
  3. Dhami S, Nurmatov U, Arasi S, Khan T, Asaria M, Zaman H, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis. Allergy. 2017;72:1597-1631.
  4. Canonica GW, , Hellings P, Ryan D, Valovirta E, Wickman M et al. Allergen Immunotherapy (AIT): a prototype of Precision Medicine. World Allergy Organ J. 2015;10;8:31.
  5. Letrán A, Espinazo M, Moreno F. Measurement of IgE to pollen allergen components is helpful in selecting patients for immunotherapy. Ann Allergy Asthma Immunol. 2013;111:295-7.
  6. Stringari G, Tripodi S, Caffarelli C, Dondi A, Asero R, Di Rienzo Businco A. The effect of component-resolved diagnosis on specific immunotherapy prescription in children with hay fever. J Allergy Clin Immunol. 2014;134:75-81.
  7. Assing K, Bodtger U, Poulsen LK, Malling HJ. Grass pollen symptoms interfere with the recollection of birch pollen symptoms – a prospective study of suspected, asymptomatic skin sensitization. Allergy 2007:62:373-77.
  8. Valenta R, Twaroch T, Swoboda I. Component-resolved diagnosis to optimize allergen-specific immunotherapy in the Mediterranean area. J Investig Allergol Clin Immunol. 2007;17 Suppl 1:36-40.
  9. Douladiris N, Savvatianos S, Roumpedaki I, Skevaki C, Mitsias D, Papadopoulos NG. A molecular diagnostic algorithm to guide pollen immunotherapy in southern Europe: towards component-resolved management of allergic diseases. Int Arch Allergy Immunol. 2013;162:163-72.
  10. Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, Valenta R, Hilger C, Hofmaier S et al. EAACI Molecular Allergology User’s Guide. Pediatr Allergy Immunol. 2016;27 Suppl 23:1-250.
  11. Melioli G, Spenser C, Reggiardo G, Passalacqua G, Compalati E, Rogkakou A, et al. Allergenius, an expert system for the interpretation of allergen microarray results. World Allergy Organ J. 2014;7:15.
  12. Matricardi PM, Dramburg S, Alvarez-Perea A, et al. The role of mobile health technologies in allergy care: An EAACI position paper. Allergy. 2020;75(2):259-272.
  13. Bédard A, Basagaña X, Anto JM, Garcia-Aymerich J, Devillier P, Arnavielhe S et al. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study. J Allergy Clin Immunol. 2019;144:135-143.e6.
  14. Florack J, Brighetti MA, Perna S, Pizzulli A, Pizzulli A, Tripodi S et al. Comparison of six disease severity scores for allergic rhinitis against pollen counts a prospective analysis at population and individual level. Pediatr Allergy Immunol. 2016;27:382-90.
  15. Tripodi S, Giannone A, Sfika I, et al. Digital technologies for an improved management of respiratory allergic diseases: 10 years of clinical studies using an online platform for patients and physicians. Ital J Pediatr. 2020;46(1):105.
  16. Bastl K, Bastl M, Bergmann KC, Berger M, Berger U. Translating the Burden of Pollen Allergy Into Numbers Using Electronically Generated Symptom Data From the Patient’s Hayfever Diary in Austria and Germany: 10-Year Observational Study. J Med Internet Res. 2020;22(2):e16767. Published 2020 Feb 21. doi:10.2196/16767
  17. Di Fraia M, Tripodi S, Arasi S, et al. Adherence to Prescribed E-Diary Recording by Patients With Seasonal Allergic Rhinitis: Observational Study. J Med Internet Res. 2020;22(3):e16642.
  18. Courbis AL, Murray RB, Arnavielhe S, Caimmi D, Bedbrook A, Van Eerd M et al. Electronic Clinical Decision Support System for allergic rhinitis management: MASK e-CDSS. Clin Exp Allergy. 2018;48:1640-1653.
  19. Matricardi PM, Potapova E, Forchert L, Dramburg S, Tripodi S. Digital allergology: Towards a clinical decision support system for allergen immunotherapy. Pediatr Allergy Immunol. 2020;31 Suppl 24:61-64.
  20. Lourenço O, Bosnic-Anticevich S, Costa E, et al. Managing Allergic Rhinitis in the Pharmacy: An ARIA Guide for Implementation in Practice. Pharmacy (Basel). 2020;8(2):E85. Published 2020 May 16.
  21. Dramburg S, Marchante Fernandez M, Potapova E and Matricardi PM (2020) The Potential of Clinical Decision Support Systems for Prevention, Diagnosis, and Monitoring of Allergic Diseases. Front. Immunol. 11:2116. doi: 10.3389/fimmu.2020.02116
  22. Jabez Christopher J, Khanna Nehemiah H, Kannan A. A clinical decision support system for diagnosis of Allergic Rhinitis based on intradermal skin tests. Comput Biol Med. 2015:1;65:76-84.
  23. Di Fraia M, Arasi S, Castelli S, et al. A new molecular multiplex IgE assay for the diagnosis of pollen allergy in Mediterranean countries: A validation study. Clin Exp Allergy. 2019;49(3):341-349.
  24. Matricardi PM, Potapova E, Forchert L, Dramburg S, Tripodi S. Digital allergology: Towards a clinical decision support system for allergen immunotherapy. Pediatr Allergy Immunol. 2020;31 Suppl 24:61-64.
  25. Lockey RF, Hankin CS. Health economics of allergen-specific immunotherapy in the United States. J Allergy Clin Immunol. 2011;127:39-43.
  26. Migueres M, Dávila I, Frati F, Azpeitia A, Jeanpetit Y, Lhéritier-Barrand M et al. Types of sensitization to aeroallergens: definitions, prevalences and impact on the diagnosis and treatment of allergic respiratory disease. Clin Transl Allergy 2014;4:16.
  27. Hertzog MA. Considerations in determining sample size for pilot studies. Res Nurs Health. 2008;31:180-91.